88 related articles for article (PubMed ID: 21960226)
21. Trends in ultrasensitive proteomics.
Altelaar AF; Heck AJ
Curr Opin Chem Biol; 2012 Apr; 16(1-2):206-13. PubMed ID: 22226769
[TBL] [Abstract][Full Text] [Related]
22. Targeting cancer with small-molecular-weight kinase inhibitors.
Fabbro D; Cowan-Jacob SW; Möbitz H; Martiny-Baron G
Methods Mol Biol; 2012; 795():1-34. PubMed ID: 21960212
[TBL] [Abstract][Full Text] [Related]
23. Phosphoproteome profile of human lung cancer cell line A549.
Yu G; Xiao CL; Lu CH; Jia HT; Ge F; Wang W; Yin XF; Jia HL; He JX; He QY
Mol Biosyst; 2011 Feb; 7(2):472-9. PubMed ID: 21060948
[TBL] [Abstract][Full Text] [Related]
24. Quantitative proteome and phosphoproteome analysis of human pluripotent stem cells.
Muñoz J; Heck AJ
Methods Mol Biol; 2011; 767():297-312. PubMed ID: 21822884
[TBL] [Abstract][Full Text] [Related]
25. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways.
Yan GR; Xiao CL; He GW; Yin XF; Chen NP; Cao Y; He QY
Proteomics; 2010 Mar; 10(5):976-86. PubMed ID: 20049867
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies.
Hammer E; Goritzka M; Ameling S; Darm K; Steil L; Klingel K; Trimpert C; Herda LR; Dörr M; Kroemer HK; Kandolf R; Staudt A; Felix SB; Völker U
J Proteome Res; 2011 May; 10(5):2161-71. PubMed ID: 21417265
[TBL] [Abstract][Full Text] [Related]
27. Covalent cross-linking of kinases with their corresponding peptide substrates.
Statsuk AV; Shokat KM
Methods Mol Biol; 2012; 795():179-90. PubMed ID: 21960223
[TBL] [Abstract][Full Text] [Related]
28. Proteomics characterization of gastrokine 1-induced growth inhibition of gastric cancer cells.
Yan GR; Xu SH; Tan ZL; Yin XF; He QY
Proteomics; 2011 Sep; 11(18):3657-64. PubMed ID: 21751384
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling.
Zhang L; Holmes IP; Hochgräfe F; Walker SR; Ali NA; Humphrey ES; Wu J; de Silva M; Kersten WJ; Connor T; Falk H; Allan L; Street IP; Bentley JD; Pilling PA; Monahan BJ; Peat TS; Daly RJ
J Proteome Res; 2013 Jul; 12(7):3104-16. PubMed ID: 23692254
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants.
Skaggs BJ; Gorre ME; Ryvkin A; Burgess MR; Xie Y; Han Y; Komisopoulou E; Brown LM; Loo JA; Landaw EM; Sawyers CL; Graeber TG
Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19466-71. PubMed ID: 17164333
[TBL] [Abstract][Full Text] [Related]
31. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
Yocum AK; Busch CM; Felix CA; Blair IA
J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
[TBL] [Abstract][Full Text] [Related]
32. Absolute Phosphorylation Stoichiometry Analysis by Motif-Targeting Quantitative Mass Spectrometry.
Tsai CF; Ku WC; Chen YJ; Ishihama Y
Methods Mol Biol; 2017; 1636():313-325. PubMed ID: 28730488
[TBL] [Abstract][Full Text] [Related]
33. A targeted quantitative proteomics strategy for global kinome profiling of cancer cells and tissues.
Xiao Y; Guo L; Wang Y
Mol Cell Proteomics; 2014 Apr; 13(4):1065-75. PubMed ID: 24520089
[TBL] [Abstract][Full Text] [Related]
34. Determination of kinase inhibitor potencies in cell extracts by competition binding assays and isobaric mass tags.
Hopf C; Eberhard D; Boesche M; Bastuck S; Dümpelfeld B; Bantscheff M
Methods Mol Biol; 2012; 803():141-55. PubMed ID: 22065223
[TBL] [Abstract][Full Text] [Related]
35. Multiplex imaging and cellular target identification of kinase inhibitors via an affinity-based proteome profiling approach.
Su Y; Pan S; Li Z; Li L; Wu X; Hao P; Sze SK; Yao SQ
Sci Rep; 2015 Jan; 5():7724. PubMed ID: 25579846
[TBL] [Abstract][Full Text] [Related]
36. Proteomic Profiling of Protein Kinase Inhibitor Targets by Mass Spectrometry.
Golkowski M; Maly DJ; Ong SE
Methods Mol Biol; 2017; 1636():105-117. PubMed ID: 28730476
[TBL] [Abstract][Full Text] [Related]
37. Large-scale models of signal propagation in human cells derived from discovery phosphoproteomic data.
Terfve CD; Wilkes EH; Casado P; Cutillas PR; Saez-Rodriguez J
Nat Commun; 2015 Sep; 6():8033. PubMed ID: 26354681
[TBL] [Abstract][Full Text] [Related]
38. Strategies for kinome profiling in cancer and potential clinical applications: chemical proteomics and array-based methods.
Piersma SR; Labots M; Verheul HM; Jiménez CR
Anal Bioanal Chem; 2010 Aug; 397(8):3163-71. PubMed ID: 20526883
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of kinase inhibitor selectivity by chemical proteomics.
Daub H; Godl K; Brehmer D; Klebl B; Müller G
Assay Drug Dev Technol; 2004 Apr; 2(2):215-24. PubMed ID: 15165517
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Kinase Activity Profiling Using Chemical Proteomics.
Ruprecht B; Zecha J; Heinzlmeir S; Médard G; Lemeer S; Kuster B
ACS Chem Biol; 2015 Dec; 10(12):2743-52. PubMed ID: 26378887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
